Karin Bianu-Yaacoby

Merkaz Hakarmel, HA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Correlation between pulmonary outcomes and nutritional status following treatment with elexacaftor/tezacaftor/ivacaftor in people with Cystic fibrosis.

Correlation between pulmonary outcomes and nutritional status following treatment with elexacaftor/tezacaftor/ivacaftor in people with Cystic fibrosis.

Journal: Respiratory medicine

Published: February 23, 2026

Non-tuberculous mycobacteria in primary ciliary dyskinesia: a national multicenter cohort study.

Non-tuberculous mycobacteria in primary ciliary dyskinesia: a national multicenter cohort study.

Journal: Respiration; international review of thoracic diseases

Published: January 18, 2026

Nontuberculous Mycobacteria in Primary Ciliary Dyskinesia: A National Multicenter Cohort Study.

Nontuberculous Mycobacteria in Primary Ciliary Dyskinesia: A National Multicenter Cohort Study.

Journal: Respiration; international review of thoracic diseases

Published: January 18, 2026

Pulmonary exacerbations in cystic fibrosis after fatherhood with and without CFTR modulators.

Pulmonary exacerbations in cystic fibrosis after fatherhood with and without CFTR modulators.

Journal: Respiratory medicine

Published: December 10, 2025

Vaccine Coverage Among People With Cystic Fibrosis: A National Multicenter Cross-Sectional Study in Israel.

Vaccine Coverage Among People With Cystic Fibrosis: A National Multicenter Cross-Sectional Study in Israel.

Journal: Pediatric pulmonology

Published: February 22, 2025

Medical clown intervention shortens length of hospitalization in children with pneumonia.

Medical clown intervention shortens length of hospitalization in children with pneumonia.

Journal: Scientific reports

Published: January 06, 2025

Screening and monitoring across the lifespan of an ageing cystic fibrosis population.

Screening and monitoring across the lifespan of an ageing cystic fibrosis population.

Journal: ERJ open research

Published: December 18, 2024

Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis with Mildly Decreased and Normal Lung Function: A Real-Life Observational Study.

Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis with Mildly Decreased and Normal Lung Function: A Real-Life Observational Study.

Journal: Annals of the American Thoracic Society

Published: July 25, 2024

Treatment effects of elexacaftor/tezacaftor/ivacaftor on people with cystic fibrosis heterozygous for 3849+10kbC->T and a class I variant.

Treatment effects of elexacaftor/tezacaftor/ivacaftor on people with cystic fibrosis heterozygous for 3849+10kbC->T and a class I variant.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: July 03, 2024

Treatment effects of CFTR modulators on people with cystic fibrosis carrying the Q359K/T360K variant.

Treatment effects of CFTR modulators on people with cystic fibrosis carrying the Q359K/T360K variant.

Journal: ERJ open research

Published: April 14, 2024

Optimizing CFTR modulator therapy management for cystic fibrosis through the ReX platform.

Optimizing CFTR modulator therapy management for cystic fibrosis through the ReX platform.

Journal: Frontiers in pediatrics

Published: September 23, 2023

The new face of cystic fibrosis in the era of population genetic carrier screening.

The new face of cystic fibrosis in the era of population genetic carrier screening.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: August 03, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026